ALTZAMPY Trademark

Trademark Overview

On Wednesday, July 26, 2017, a trademark application was filed for ALTZAMPY with the United States Patent and Trademark Office. The USPTO has given the ALTZAMPY trademark a serial number of 87543673. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 13, 2021. This trademark is owned by Bristol-Myers Squibb Company. The ALTZAMPY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
altzampy

General Information

Serial Number87543673
Word MarkALTZAMPY
Filing DateWednesday, July 26, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 12, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 31, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, September 13, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 13, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, February 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 11, 2021EXTENSION 5 GRANTED
Wednesday, February 3, 2021EXTENSION 5 FILED
Wednesday, February 3, 2021TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 7, 2020EXTENSION 4 GRANTED
Friday, August 7, 2020EXTENSION 4 FILED
Friday, August 7, 2020TEAS EXTENSION RECEIVED
Thursday, February 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 4, 2020EXTENSION 3 GRANTED
Tuesday, February 4, 2020EXTENSION 3 FILED
Tuesday, February 4, 2020TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 2, 2019EXTENSION 2 GRANTED
Wednesday, August 7, 2019EXTENSION 2 FILED
Saturday, November 2, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 8, 2019NOTICE OF REVIVAL - E-MAILED
Monday, October 7, 2019EXTENSION RECEIVED WITH TEAS PETITION
Monday, October 7, 2019PETITION TO REVIVE-GRANTED
Monday, October 7, 2019TEAS PETITION TO REVIVE RECEIVED
Monday, September 9, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 9, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 7, 2019EXTENSION 1 GRANTED
Thursday, February 7, 2019EXTENSION 1 FILED
Thursday, February 7, 2019TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 7, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 12, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 23, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 27, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 27, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 27, 2017NON-FINAL ACTION E-MAILED
Friday, October 27, 2017NON-FINAL ACTION WRITTEN
Thursday, October 26, 2017ASSIGNED TO EXAMINER
Monday, July 31, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 29, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

altzampy diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection